One World. One Standard.®

Epilepsy is a global problem that deserves a global solution.

doc-icon

The Challenge

The vast majority of people living with epilepsy and associated psychiatric disorders in the developed world have their disorders controlled, typically with medication. But patients in the rest of the world go without these diagnostic tools, effective treatments and basic medications.

money-icon

The Process

The ROW Foundation is pursuing change. The ROW Foundation is a shareholder of OWP Pharmaceuticals, a for-profit company that produces neurology and psychiatry medications. Profits from OWP fund the charitable projects of ROW. Working together, the two organizations are an expression of sustainable philanthropy that can change the world.

kit-icon

The Solution

The ROW Foundation provides treatment resources, including proven medications, to people with epilepsy and associated psychiatric disorders. ROW also helps neurologists and psychiatrists in the developed world train practitioners in the developing world to more effectively treat epilepsy and associated psychiatric disorders.

We share World Health Organization's belief that, “the highest attainable standard of health as a fundamental right of every human being.” In that spirit, we're working toward a world in which the same standard of care for epilepsy and associated psychiatric disorders is available to all people, at all times, in all the world.

Vision

The ROW Foundation exists to improve the lives of people living with epilepsy and associated psychiatric disorders in under-resourced areas of the world. We envision a future when the best treatments will be available to all people, at all times, in all the world.

Mission

In fulfilling our vision, the ROW Foundation works to improve the quality of training, diagnosis and treatment available to people with epilepsy and associated psychiatric disorders in under-resourced areas of the world. We partner with other organizations to maximize impact in under-served areas, both domestically and internationally.

row-vision-mission

One World. One Standard.®

The map shows our completed, ongoing and future projects. Click on highlighted countries to see what we’re doing around the world.

Completed Projects
Ongoing Projects
Future Projects
Multiple Projects

Diagnosis and Treatment Grants (Multiple)

In 2015 a diagnosis grant in the form of a 32-channel video EEG workstation was given to the Armenia League Against Epilepsy, to be placed at Arabkir Pediatric Hospital in the capital city of Yerevan. Beginning in October 2016, an ongoing treatment grant has been supplying the hospital with Roweepra (levetiracetam USP) anti-seizure medication. This is an ongoing commitment of medication, to be resupplied every six months.

Treatment Grant (Ongoing)

In 2016, a treatment grant was provided to Solidarity Bridge/Puente Solidaridad for use in the epilepsy treatment project at Hospital Materno Infantil in Cochabamba, Bolivia. The grant provides Roweepra (levetiracetam USP) for epilepsy patients being treated at the hospital. This is an ongoing commitment of medication, to be resupplied as needed.

Diagnosis Grant (Future)

The ROW Foundation is hoping to grant mobile EEG equipment to assist with the diagnosis and monitoring of epilepsy patients in outlying, under-resourced areas of Cameroon. When the grant is fully implemented, EEG scans will be able to be transmitted via the internet and read by volunteer neurologists in the United States, who can then provide diagnoses to health care providers in Cameroon.

Training Grant (Completed)

In 2017, a training grant was provided to the Global Organization of Health Education (GOHE) for the purchase of technical materials to be used in training EEG technicians in Ethiopia.

Diagnosis Grant (Future)

The ROW Foundation is hoping to grant a 32-channel video EEG workstation to an epilepsy society headquartered in Accra, Ghana for use in diagnosing and monitoring epilepsy among under-resourced populations in the greater Accra area. The epilepsy society will make the equipment available through various clinics and coordinate its use.

Diagnosis Grant (Future)

The ROW Foundation is hoping to grant a 64-channel video EEG workstation to a neurology center in Guatemala City, Guatemala to assist with diagnosing and monitoring patients with epilepsy due to traumatic brain injury, and patients with forms of epilepsy resistant to typical forms of treatment.

Treatment Grant (Ongoing)

In 2017, a treatment grant was provided to Children’s Hope, a US-based nonprofit operating a medical/dental clinic in Jacmel. This grant provides Roweepra (levetiracetam USP) for epilepsy patients being treated through the clinic. This is an ongoing commitment of medication, to be resupplied as needed.

Treatment Grant (Ongoing)

In 2018 a treatment grant of Roweepra (levetiracetam USP) anti-seizure medication was provided to the CLIDEP Epilepsy Clinics in Haiti to augment medications available locally for treating patients with epilepsy. Initially the medication will be used for the CLIDEP clinics in Port-au-Prince and Jacmel, with possible expansion to the clinic in Mirebalais as well. This is an ongoing commitment of medication, to be resupplied every six months as needed.

Diagnosis Grant (Future)

The ROW Foundation is hoping to grant mobile EEG equipment to two rural hospitals in India. When the grants are fully implemented, EEG scans will be able to be transmitted via the internet and read by volunteer neurologists in the United States, who can then provide diagnoses to health care providers at the hospitals in India.

Diagnosis Grant (Future)

The ROW Foundation is hoping to grant a 32-channel video EEG workstation to a hospital in Jaipur, India for use in diagnosing and monitoring epilepsy among under-resourced populations in the greater Jaipur area.

Diagnosis Grant (Completed)

In 2016, mobile EEG equipment was provided to AIC Kijabe Hospital, a rural hospital in the Great Rift Valley of Kenya that had no EEG equipment, and no resident neurologists to read EEG studies. Through a grant to the Christian Medical and Dental Associations (CMDA), the equipment was placed, hospital staff were trained, and a mechanism for transmitting the EEG studies to volunteer neurologists in the United States was established. This allows volunteer neurologists to make diagnoses based on the EEG study data and to communicate with the health care providers at the hospital in Kenya who then provide treatment. Leveraged partnerships also resulted in a duplicate project at Tenwek Hospital.

Diagnosis Grant (Future)

The ROW Foundation is hoping to grant a 32-channel video EEG workstation to a hospital in Abakaliki, Nigeria for use in diagnosing and monitoring epilepsy among under-resourced populations in the greater Abakaliki area.

Diagnosis Grant (Future)

The ROW Foundation is hoping to grant a 32-channel video EEG workstation to a neurology institute in Tbilisi, Republic of Georgia. The new EEG workstation will allow the institute to diagnose under-resourced individuals with hard-to- treat epilepsies.

Treatment Grant (Ongoing)

In 2018, the ROW Foundation started providing anti-seizure medication to Loreto Clinic in the city of Makeni. Roweepra® (levetiracetam USP) anti-seizure medication augments locally available medication for treating patients with epilepsy. This is an ongoing commitment of medication, with the possibility of expanding to three additional sites.

Diagnosis Grant (Future)

The ROW Foundation is hoping to grant a 32-channel video EEG workstation to an epilepsy society in Mbabane, Swaziland for use in diagnosing and monitoring epilepsy patients in outlying, under-resourced areas.

Treatment Grant (Ongoing)

In 2017, the ROW Foundation committed to providing anti-seizure medication to Kigoma Baptist Hospital in the city of Kigoma. Roweepra (levetiracetam USP) anti-seizure medication will be provided to augment the locally available medications available for treating patients with epilepsy. This is an ongoing commitment of medication, to be resupplied as needed.

Treatment Grant (Completed)

In 2017, a grant was provided to the Guiding Light Orphans (GLO) organization in Uganda to assist with the purchase of locally-available anti-seizure medications, and to support operation of their mobile epilepsy clinics.

Treatment Grant (Ongoing)

In 2017, a treatment grant was provided to CURE Children’s Hospital of Uganda, located in Mbale. This grant provides Roweepra (levetiracetam USP) to augment the locally available medications available for treating patients with epilepsy. This is an ongoing commitment of medication, to be resupplied every six months.

Treatment Grant (Completed)

In 2016, a grant was provided to Epilepsy Health Management (EHM) to assist with modifications to a local epilepsy clinic in northern Illinois that will allow epilepsy patients with mobility issues – often as a result of traumatic brain injury – access services more easily.

Treatment Grant (Ongoing)

In 2017, treatment grants were made to two Epilepsy Foundation chapters in the United States: one to the Epilepsy Foundation of North Carolina, and the other to the Epilepsy Foundation of North/Central Illinois. The grants consisted of Roweepra (levetiracetam USP) and are being used to provide care for epilepsy patients temporarily unable to access care independently. The ROW Foundation is open to providing similar treatment grants to Epilepsy Foundations operating treatment clinics and serving under-resourced populations.

Treatment Grant (Completed)

In October 2017 ROW partnered with the Epilepsy Foundation of Greater Chicago and Dr. Rebecca Garcia Sosa of Lurie Children’s Hospital in Chicago to deliver a medication humanitarian aid shipment to Hospital Pediátrico Universitario (HOPU) in San Juan , Puerto Rico in the aftermath of Hurricane Maria. HOPU had been designated as a central hub for the receipt of medication humanitarian relief, and Dr. Janice Rodriguez Hernandez, Child Neurology Chief Resident, Fundación Hospital Pediátrico, was responsible for coordinating the distribution of the medication to where it was most needed until commercial pharmaceutical distribution could be restored. This was ROW’s largest single grant to-date, representing about $35,000 worth of medication.

Recent Updates

February 8, 2018

Sierra Leone Treatment Grant

August 23, 2017

More People Living with Epilepsy

August 7, 2017

Expanded Purpose

Make Your Mark

Your charitable contributions allow you to make your mark on the world!

Make Your Mark!